Amnioinfusion with ulinastatin to Chronic Abruption-Oligohydramnions Sequence

Amnioinfusion with ulinastatin to Chronic Abruption-Oligohydramnions Sequence - Amnioinfusion with ulinastatin to Chronic Abruption-Oligohydramnions Sequence

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000010557

Enrollment

Registered

2013-06-01

Start date

2013-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Abruption-Oligohydramnions Sequence

Interventions

We puncture amniotic fluid cavity with a needle through maternal abdomen guided by ultrasound and infuse saline solution with ulinastatin.

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Patients prior to the 26th week of gestational age with placental abruption which genital bleeding last for more than 7 days, and complicated by oligohydramnion without the evidence of premature rupture of membrane are included.

Exclusion criteria

Exclusion criteria: Criteria for exclusion from the study include conditions of labor onset, clinical chorioamnionitis and non- reassuring fetal status.

Design outcomes

Primary

Measure	Time frame
We examine whether we could prevent or reduce the risk of neonatal lung disorder or not.	—

Countries

Japan

Contacts

Public ContactKaoru Kawasaki

Kyoto University, Graduate School of Medicine Obstetrics and Gynecology

kkaoru@kuhp.kyoto-u.ac.jp075-751-3269

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026